Germany’s Next Coalition Nears Deal On Legalizing Cannabis
Germany’s likely next ruling coalition is closing in on a deal to legalize cannabis for recreational use, the strongest signal yet that long-awaited growth of Europe’s marijuana market is gaining traction.
Negotiators for the Social Democrats, Greens and pro-business Free Democrats are hammering out the details, including conditions under which the sale and use of recreational cannabis would be allowed and regulated, according to people familiar with the talks, who asked not to be identified because the discussions are private.
They’re part of wider negotiations on forming a new government, with the three parties targeting early December for a new administration to take office under Social Democrat Olaf Scholz.
– Read the entire article at Bloomberg News.
420GrowLife
via www.KahliBuds.com
Eyk Henning, Aaron Kirchfeld and Tiffany Kary, Bloomberg News, KahliBuds, 420GrowLife
Malaysia to Allow Import and Use of Medical Cannabis
420GrowLife
via www.KahliBuds.com
Anuradha Raghu and Archie Hunter, Bloomberg News, KahliBuds, 420GrowLife
420GrowLife
via www.KahliBuds.com
Keshia Clukey, Bloomberg News, KahliBuds, 420GrowLife
Method Man, the actor and rapper known for his work with Wu-Tang Clan, is launching a cannabis business that aims to bring more black ownership to the industry.
Tical, named after his 1994 solo debut album, will start selling marijuana to four black-owned dispensaries as soon as this weekend, said spokesman Neal Kwatra. The company, whose name stands for “Taking Into Consideration All Lives,” has raised US$300,000 with New York-based JLS Fund for its initial launch, and aims to bring in US$3 million for a nationwide rollout.
“Personally, it is essential that we use our brand to help bring awareness to the social, systemic and economic injustice in communities that have struggled with oppressive mass incarceration and racially biased policing policies,” Method Man said in a statement.
– Read the entire article at BNN Bloomberg.
420GrowLife
via www.KahliBuds.com
Tiffany Kary, Bloomberg News, KahliBuds, 420GrowLife

Tilray Inc. shares jumped as much as 14 per cent after announcing it successfully imported medical cannabis into the U.S. in support of a clinical trial studying its efficacy in treating patients with disorders caused by breast cancer treatments.
The study will focus on patients suffering from taxane-induced peripheral neuropathy, or TIPN, secondary to treatment with paclitaxel or docetaxel. TIPN affects more than 67 per cent of women undergoing breast cancer treatment, the company said.
“Tilray is committed to advancing cannabis research through its support of clinical trials around the world as we continue to enhance our understanding of the potential benefits of medical cannabis,” Philippe Lucas, vice president of global patient research and access, said in a statement.
– Read the entire article at BNN Bloomberg.
420GrowLife
via www.KahliBuds.com
Gregory Calderone, Bloomberg News, KahliBuds, 420GrowLife